THG is trading at £32.00, up 16.28%, after lifting its 2026 adjusted EBITDA outlook to £103 million, above analyst consensus of £101.7 million, on stronger nutrition performance.
- Strong sports nutrition and supplement demand, plus more favourable whey protein prices, supported the upgrade.
- Reuters reported third-quarter revenue grew 1.5% to £408.8 million and nutrition grew 5.3% to £152.4 million.
- Reuters reported shares rose as much as 10% in early trading on October 15; price context shows a 16.28% gain.